Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema

Abstract Some patients treated with dupilumab for atopic dermatitis (AD) develop resistance on their face, despite achieving good response on other body parts. The pathomechanisms of dupilumab‐resistant facial erythema (DRFE) are unclear and its treatment is challenging. We report a case of DRFE res...

Full description

Bibliographic Details
Main Authors: Takeshi Fukumoto, Chikako Nishigori
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:JEADV Clinical Practice
Subjects:
Online Access:https://doi.org/10.1002/jvc2.70
_version_ 1811213488785195008
author Takeshi Fukumoto
Chikako Nishigori
author_facet Takeshi Fukumoto
Chikako Nishigori
author_sort Takeshi Fukumoto
collection DOAJ
description Abstract Some patients treated with dupilumab for atopic dermatitis (AD) develop resistance on their face, despite achieving good response on other body parts. The pathomechanisms of dupilumab‐resistant facial erythema (DRFE) are unclear and its treatment is challenging. We report a case of DRFE resistant to topical corticosteroids and delgocitinib that was successfully treated with tacrolimus ointment. Tacrolimus ointment was not effective for his facial AD before dupilumab initiation but was effective for DRFE, suggesting that DRFE has a different pathomechanism from AD.
first_indexed 2024-04-12T05:47:37Z
format Article
id doaj.art-43e7809bc6cf4c3a9924bb6234e0395d
institution Directory Open Access Journal
issn 2768-6566
language English
last_indexed 2024-04-12T05:47:37Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series JEADV Clinical Practice
spelling doaj.art-43e7809bc6cf4c3a9924bb6234e0395d2022-12-22T03:45:24ZengWileyJEADV Clinical Practice2768-65662022-12-011442742910.1002/jvc2.70Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythemaTakeshi Fukumoto0Chikako Nishigori1Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe JapanDivision of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe JapanAbstract Some patients treated with dupilumab for atopic dermatitis (AD) develop resistance on their face, despite achieving good response on other body parts. The pathomechanisms of dupilumab‐resistant facial erythema (DRFE) are unclear and its treatment is challenging. We report a case of DRFE resistant to topical corticosteroids and delgocitinib that was successfully treated with tacrolimus ointment. Tacrolimus ointment was not effective for his facial AD before dupilumab initiation but was effective for DRFE, suggesting that DRFE has a different pathomechanism from AD.https://doi.org/10.1002/jvc2.70dermoscopydupilumabdupilumab‐resistant facial erythemaMalasseziatacrolimus ointment
spellingShingle Takeshi Fukumoto
Chikako Nishigori
Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
JEADV Clinical Practice
dermoscopy
dupilumab
dupilumab‐resistant facial erythema
Malassezia
tacrolimus ointment
title Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
title_full Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
title_fullStr Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
title_full_unstemmed Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
title_short Effectiveness of tacrolimus ointment for dupilumab‐resistant facial erythema
title_sort effectiveness of tacrolimus ointment for dupilumab resistant facial erythema
topic dermoscopy
dupilumab
dupilumab‐resistant facial erythema
Malassezia
tacrolimus ointment
url https://doi.org/10.1002/jvc2.70
work_keys_str_mv AT takeshifukumoto effectivenessoftacrolimusointmentfordupilumabresistantfacialerythema
AT chikakonishigori effectivenessoftacrolimusointmentfordupilumabresistantfacialerythema